Effects of TOT on Performance, Independence and Fatigue in Children With Cancer

NCT04405531 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 213

Last updated 2020-05-28

No results posted yet for this study

Summary

This study aims to explore the effects of Task-Oriented Training (TOT) on occupational performance, activities of daily living and fatigue of children in pediatric oncology clinic.

Hypothesis: There is no effect of TOT on occupational performance and satisfaction in children with childhood cancer. There is no effect of TOT on functional independence in daily living activities in children with childhood cancer. There is no effect of TOT on fatigue levels in children with childhood cancer.

Conditions

  • Childhood Cancer
  • Performance
  • Functional Independence
  • Fatigue

Interventions

OTHER

task-oriented training (TOT)

The study group received a TOT together with a conventional occupational therapy (COT). The study groups received a treatment for 20 sessions at a hospital setting.

OTHER

conventional occupational therapy (COT)

The control group received only a COT program. The control groups received a treatment for 20 sessions at a hospital setting.

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Principal Investigators

  • Zeynep Kolit, MSc · Hacettepe University

  • Sedef Şahin, PhD · Hacettepe University

  • Ceren Davutoğlu, MSc · Hacettepe University

  • Meral Huri, PhD · Hacettepe University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-01-03
Completion
2020-01-13

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04405531 on ClinicalTrials.gov